NCLEX-PN
NCLEX-PN Quizlet 2023 Questions
Extract:
Question 1 of 5
A healthcare professional is reviewing a patient's current Lithium levels. Which of the following values is outside the therapeutic range?
Correct Answer: D
Rationale: The correct answer is 1.3 mEq/L. The therapeutic range for Lithium levels typically falls between 0.6 to 1.2 mEq/L. Values below or above this range can lead to suboptimal treatment outcomes or toxicity.
Choices A, B, and C are within the therapeutic range of 1.0-1.2 mEq/L, making them appropriate levels for patient care.
Question 2 of 5
Erythropoietin used to treat anemia in clients with renal failure should be given in conjunction with:
Correct Answer: A
Rationale: Erythropoietin is necessary for red blood cell (RB
C) production, and in clients with renal failure who lack endogenous erythropoietin, exogenous erythropoietin is administered. However, for erythropoietin to effectively stimulate RBC production, adequate levels of iron, folic acid, and vitamin B12 are crucial. These nutrients are essential for RBC synthesis and maturation.
Therefore, the correct answer is to give iron, folic acid, and B12 with erythropoietin.
Choice B, an increase in protein in the diet, is not necessary for RBC production and may exacerbate uremia in clients with renal failure.
Choices C and D, vitamins A and C, and an increase in calcium in the diet, respectively, are not directly related to RBC production and are not required to enhance the effectiveness of erythropoietin.
Question 3 of 5
In the treatment of symptomatic bradycardia, which medication is most commonly recognized?
Correct Answer: D
Rationale: Atropine is the medication most commonly recognized for the treatment of symptomatic bradycardia because it increases the rate of conduction in the AV node, helping to alleviate bradycardia. Questran is a medication used to lower cholesterol levels and is not indicated for bradycardia. Digitalis, such as Digoxin, is used for heart failure and atrial fibrillation but not typically for bradycardia. Nitroglycerin is primarily used for angina and not bradycardia.
Question 4 of 5
A patient has been diagnosed with Guillain-Barre Syndrome. Which of the following statements is the most applicable when discussing the impairments with Guillain-Barre Syndrome with the patient?
Correct Answer: C
Rationale: The correct statement is that Guillain-Barre Syndrome causes muscle weakness in the legs. This muscle weakness typically starts in the legs and can progress to the upper body.
Choice A is incorrect as while most cases do improve, the recovery time can vary.
Choice B is incorrect as Guillain-Barre Syndrome primarily affects muscle weakness rather than sensation.
Choice D is incorrect as severe cases of Guillain-Barre Syndrome can lead to respiratory muscle weakness, impacting breathing.
Question 5 of 5
Which of the following diseases or conditions is least likely to be associated with an increased potential for bleeding?
Correct Answer: C
Rationale: Pernicious anemia is least likely to be associated with an increased potential for bleeding. Pernicious anemia results from vitamin B12 deficiency due to a lack of intrinsic factor, leading to faulty absorption from the gastrointestinal tract. While pernicious anemia can lead to other health issues, bleeding tendencies are not a primary concern. Metastatic liver cancer (choice
A) can cause liver dysfunction leading to decreased synthesis of clotting factors, increasing the risk of bleeding. Gram-negative septicemia (choice
B) can lead to disseminated intravascular coagulation (DI
C) causing excessive bleeding. Iron-deficiency anemia (choice
D) can result in microcytic hypochromic red blood cells, which can impair oxygen transport and lead to tissue hypoxia, but it is not directly associated with a significant potential for bleeding.